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Abstract
Objective: Male reproductive dysfunction and subsequent infertility are major complications that are 
becoming increasingly associated with Diabetes Mellitus (DM). Due to frequent failure in treatment with 
orthodox antidiabetic drugs, there has been a massive shift of attention to alternative therapies. The 
antidiabetic potential of a large number of medicinal plants have been investigated both in-vitro and in 
experimental animal models. These specific plants were predominantly used because of the antioxidant 
capacity of their bioactive phytoconstituents. This review focuses on reproductive dysfunctions 
commonly suffered by male diabetic patients and medicinal plants that have been tested and reported for 
their roles in ameliorating such dysfunctions.
Method: All original journal articles and reviews cited on PubMed between 2005 and 2015 in English 
language were considered for this review.
Results and conclusion: This review reestablished the fact that male infertility is a common complication 
of poorly managed diabetes mellitus. It also highlighted the fact that the numerous challenges associated 
with the use of orthodox drugs in management of the disease makes medicinal plant therapy inevitable. 
However, the full potentials of these medicinal plants at correcting reproductive complications of the 
disease are still to be realized and more specific studies are required in this field for improved therapeutic 
outcomes.
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Les complications reproductives chez l'homme du diabète sucré et des 
remèdes possibles pour les plantes médicinales: un examen.
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Resume
Objectif: Le dysfonctionnement reproducteur masculin et l'infertilité subséquente sont des complications 
majeures qui sont de plus en plus associées au diabète sucré (DM). En raison de l'échec fréquent dans le 
traitement avec les médicaments antidiabétiques orthodoxes, il y a eu un changement massif d'attention 
aux thérapies alternatives. Le potentiel antidiabétique d'un grand nombre de plantes médicinales a été 
étudié à la fois in vitro et dans des modèles animaux expérimentaux. Ces plantes spécifiques ont été 
principalement utilisées en raison de la capacité antioxydante de leurs phytoconstituants bioactifs. Cette 
revue se concentre sur les dysfonctionnements reproductifs couramment subis par les patients diabétiques 
mâles et les plantes médicinales qui ont été testés et rapportés pour leurs rôles dans l'amélioration de ces 
dysfonctionnements.
Méthode: Tous les articles de revues originales et les critiques cités sur PubMed entre 2005 et 2015 en 
langue anglaise ont été considérés pour cette revue.
Résultats et conclusion: Cette revue a rétabli le fait que l'infertilité masculine est une complication 
fréquente du diabète sucré mal géré. Il a également souligné le fait que les nombreux défis associés à 
l'utilisation de médicaments orthodoxes dans la prise en charge de la maladie rendent inévitable la thérapie 
par les plantes médicinales. Cependant, les pleins potentiels de ces plantes médicinales pour corriger les 
complications reproductives de la maladie doivent encore être réalisés et des études plus spécifiques sont 
nécessaires dans ce domaine pour améliorer les résultats thérapeutiques.
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INTRODUCTION
In 2012, the American Diabetes 
Association defined Diabetes Mellitus (DM) as a 
group of metabolic diseases characterized by 
hyperglycaemia and resulting from defects in 
insulin secretion, insulin action, or both (1). Two 
major etiopathogenetic classes of DM namely, 
type 1 or Insulin Dependent DM (IDDM) and 
type 2 or Non-Insulin Dependent DM (NIDDM) 
are widely recognized (1). Insulin Dependent 
Diabetic Mellitus is caused by absolute insulin 
deficiency due to autoimmune destruction of the 
pancreatic â-islet cells, while NIDDM is usually 
as a result of a combination of insulin resistance 
and inadequate compensatory insulin release 
response (1). The main feature of DM is chronic 
hyperglycaemia which results in long-term 
damage, dysfunction, and failure of different 
organs, involving virtually all systems of the 
body. Diabetes is a major public health challenge, 
increasingly affecting millions of people across 
all age groups worldwide (2). If not well 
managed, it results in a wide range of 
complications including neuropathy, retinopathy, 
cardiovascular diseases, renal diseases and 
reproductive dysfunction (2).
A large number of studies, both in 
diabetic humans and animal models associated 
DM with impotence, erectile dysfunction, 
retrograde ejaculation and hypogonadism (2). 
Despite this, the disease was not directly linked 
with male infertility until recently when findings 
revealed that diabetes induces subtle molecular 
alterations which are very paramount to 
spermatogenesis and sperm physiology (3). The 
role of DM in the incidence of male infertility is 
poorly reported and available data is 
character ized with controversies  and 
inconsistencies (4). However, due to the 
conflicting reports on the influence of diabetes on 
the endocrine control of spermatogenesis, it was 
concluded that, DM may affect male 
reproductive function at multiple levels and the 
individual anomalies may not have any 
significant effect on reproductive function (5).
There has been a major upsurge in the 
number of research publications on DM in the last 
decade with special attention towards finding 
alternative plant remedies for the troublesome 
disease. Often, the attention is fixed on the ability 
of these plant agents to restore glycaemic control 
and reverse hyperglycaemia with little recourse 
to the correction of the disease complications. 
This review focuses on the reported male 
reproductive complications of DM and the 
medicinal plant materials that have been 
investigated for their efficacies in correcting such 
complications. 
MATERIALS AND METHODS
This review considered all original 
journal papers and reviews cited on PubMed from 
2005 to 2015. Few selected, exceptionally 
relevant publications outside this period were 
also reviewed. Only the studies published in 
English language were considered and keywords 
such as; 'Diabetes mellitus, definition and 
complications, medicinal plant treatment, 
diabetes mellitus and male reproductive 
dysfunction' were used for the search.
Male Reproductive dysfunctions in diabetes 
mellitus
Diabetes mellitus is not routinely 
investigated in cases of male infertility due to the 
scanty and conflicting research findings on the 
subject matter, but this may start to change in the 
wake of recent reports. La Vignera et al. (4) 
reported 1.2% prevalence of DM in the male 
counterparts of couples that were treated for 
infertility, 35.1% infertility cases among men 
with type 2 DM, and 51% subfertility among DM 
patients in general. These reported cases of 
infertility might be attributable to the following 
reported male reproductive complications of 
DM.
Morphologic effects: DM causes a significant 
reduction in testicular weight and total number of 
Leydig cells in the testes (6, 8). This may be 
linked with the reported low testosterone levels 
and histological changes induced by DM in the 
testes (6). Hyperglycaemia was also recently 
reported to induce apoptotic damage and cause 
morphologic impairment in the testes (8). This 
could further explain the testicular changes 
observed in diabetic subjects (see Fig. 1 [ii] & 
[v]). Histologically, a regression in the absolute 
weight of the caput, corpus and caudal regions of 
the epididymis, accompanied with reduction in 
tubule and lumen size, as well as increased 
interstitial stroma has been observed in the testes 
of Streptozotocin (STZ)-induced diabetic Wistar 
rats (9).
Effects on spermatogenesis and sperm 
parameters: Several studies conducted in both 
diabetic humans and animal models revealed that 
DM may have a deleterious effect on the process 
of spermatogenesis as suggested by reports of 
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subnormal sperm parameters (3, 4, 10). 
Testosterone, the major hormone that drives 
spermatogenesis, has been found to be decreased 
in diabetic men due to impaired Leydig cell 
function (11).  There are contradictory and 
inconsistent reports with regards to the exact 
impact DM has on semen quality (3). For 
instance, Delfino et al. (12) reported that there 
was no difference in sperm concentration of 
semen samples from diabetic men when 
compared to non-diabetic controls, whereas,  
Amaral et al. (11) reported a deterioration of all 
sperm parameters including sperm density in 
diabetic men. In a separate study on diabetic and 
non-diabetic human semen, Agbaje et al. (5) 
found a positive association between DM and 
sperm nuclear and mitochondrial DNA damage, 
in spite of zero effect on the conventional semen 
parameters (see Fig. 1 [iii]). The controversy 
deepened recently when a study, designed to 
evaluate the isolated effect of high glucose 
concentration on human semen reported that 
'high glucose levels per se have no adverse effect 
on sperm function in vitro' (13). However, it can 
be deduced from the overwhelming majority of 
literature reports that spermatogenesis and 
consequently, at least one or more of the 
parameters determining semen quality and 
fertility (namely: sperm count, sperm 
concentration, motility, kinetics, morphology, 
semen fructose/glucose level, semen pH and 
semen volume) are adversely affected by DM (4, 
5, 11, 14).
Effects on sexual behaviour: The processes 
controlling male libido, penile erection and 
ejaculation are largely autonomic, and DM is 
known to be complicated by autonomic 
neuropathy (2). One of the most reported 
reproductive complications of DM in men is 
Erectile Dysfunction (ED) (15). It simply means 
the inability to achieve and/or sustain penile 
erection long enough for adequate sexual 
relations (11). The prevalence of ED among 
diabetic men ranges from 20% to 85% and the 
etiology can be from either one or a combination 
of any of vascular, neurological and endocrine 
anomalies (15). Moore and Wang (16) reported 
that ED affects 32% of IDDM and 46% NIDDM 
patients and is found to be the presenting 
complaint in about 12% of all diabetic patients 
(16). Another report, however, places the 
prevalence of ED in NIDDM at 75% (17), thus, 
emphasizing the variability of occurrence in 
different populations of diabetic patients. The 
pathophysiology of ED in diabetic patients is 
multifactorial and includes: end organ damage by 
Advanced Glycation End-products (AGEs), 
increased oxygen free radicals, decreased smooth 
muscle in the corpus cavernosum due to 
increased apoptosis, impaired nitric oxide 
synthesis, nitric oxide-cyclic guanosine 
monophosphate  (NO-cGMP) pa thway 
dysfunction and effects of comorbid conditions, 
among others (16, 18, 19) (see Fig. 1 [iv]). All 
these causes of ED were recently reported to 
culminate in up-regulation of the Transforming 
Growth Factor â1/Smad (TGF-â1/Smad) 
signaling pathway which is a final common 
pathway of tissue insult (20).
Ejaculatory dysfunction secondary to 
autonomic neuropathy syndrome and depletion 
in serum testosterone level is another common 
sequela of DM (21). This dysfunction actually 
describes a range of anomalies from premature 
ejaculation to total failure of ejaculation (such as 
anejaculation or retrograde ejaculation), and DM 
is a common cause (22). Pontes and colleagues 
(21) conducted an extensive study on the role of 
testosterone supplementation in diabetic male 
Wistar rats that exhibited reduced sexual activity 
and failure of ejaculation. They reported only 
33.3% sexual activity and ejaculation in diabetic 
rats as compared to 89.0% in the control group. 
Ejaculatory behaviour improved to about 62.5% 
a f t e r  t h r e e  w e e k s  o f  t e s t o s t e r o n e  
supplementation, confirming their conclusion 
that DM induces ejaculatory dysfunction by 
causing low serum testosterone levels (21). 
Other disturbances in sexual function 
common in DM which are probably neurologic 
and psychological in etiology include: reduced 
libido and Retrograde Ejaculation (RE) (11). In 
RE, the semen is released into the male urinary 
bladder rather than the female genital tract during 
sexual intercourse. This is due to bladder neck 
dysfunction from DM-induced autonomic 
neuropathy (21).
Endocrinological effects: The role of abnormal 
hormone regulation in diabetic induced male 
reproductive dysfunction is multifaceted. 
Diabetic neuropathy can affect the hypothalamus 
or anterior pituitary leading to secondary 
testicular failure exhibited by low serum levels of 
gonadotropins and testosterone (23). A direct 
effect on the Leydig cells will usually result in 
primary testicular failure which in contrast to 
secondary failure, presents with low serum 
testosterone and high gonadotropin level (24) 
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(see Fig. 1 [i] & [ii]). The direct effect of insulin 
interaction with the testes and spermatozoa has 
also been suggested as a possible basis for the 
reproductive complications of DM, since both 
testes and spermatozoa themselves produce 
insulin (24). The possibility of insulin playing an 
important role in spermatogenesis was re-
emphasized by the report that the process was 
impaired in both diabetic men and knockout mice 
(2). However, it is not clear if this effect is 
induced via testicular insulin insufficiency or 
through the systemic effects of DM. 
A study recently described an association 
be tween  d iabe t i c - induced  func t iona l  
hypercortisolism and hypogonadism. The 
researchers conducted a retrospective clinical 
comparative study between fifteen diabetic 
patients with hypercortisolism and late onset 
hypogonadism and another group of fifteen non-
hypercortisolic diabetic patients also with late 
onset hypogonadism. All sexual parameters were 
found to be significantly worse in the 
hypercortisolic group and it was suggested that 
'the dysregulated hypothalamic-pituitary-adrenal 
axis has an impairing influence on sexual 
function in diabetes mellitus-associated late-
onset hypogonadism' (25). 
Medicinal plants in the treatment of diabetes-
induced male reproductive dysfunction
The management of DM as a disease 
entity is very elaborate and multidisciplinary in 
approach. Insulin therapy and/or use of oral 
antihyperglycaemic agents have been central in 
the disease management. However, the numerous 
challenges of these drugs, ranging from cost, 
dosing, administration techniques, to side effects 
among others, have necessitated a wanton shift of 
research attention to alternative therapy in 
medicinal plants.
Many medicinal plants have been used 
empirically in the treatment of male infertility 
from diverse etiologies (26), but only a few have 
been investigated for their specific roles in 
correcting or ameliorating reproductive 
dysfunctions secondary to DM.
Animal studies
Effects on the morphology of reproductive 
organs: Methanol extract of Amaranthus 
spinosus (spiny pigweed) stem was found to 
increase testicular weight significantly in STZ-
induced diabetic rats after fifteen days of oral 
administration (27). Extracts of Dracaena 
arborea (Tree Dracaena) root barks also partially 
corrected diabetes-induced morphological 
impairment of the testes and led to increased 
testicular weight in experimental rats even 
without having any significant effect on blood 
glucose after three weeks of oral treatment (7). 
This effect of D. arborea was attributed to the 
antioxidant and androgenic properties of 
saponins, phenols, flavonoids and phytosterols 
found in both aqueous and ethanol extracts of the 
plant's root (7). Allium sativum (Garlic) has 
similar positive effect on testicular weight and 
number of Leydig cells in diabetic rats and also 
ameliorated reproductive complications of STZ-
induced diabetes in pretreated rats (6). The ethyl 
acetate fraction of Eugenia jambolana (Jambul 
tree) seed, when given orally for sixty days to 
experimental diabetic rats resulted in a 
significant recovery in weights of testes and all 
accessory reproductive organs (28). Mallick et al. 
(29) investigated the effectiveness of a herbal 
mixture, MTEC, comprising of root of Musa 
paradisiaca (Banana), seeds of Tamarindus 
indica (Indian date) and Eugenia jambolana 
(Jambul) and leave of Coccinia indica (Baby 
watermelon) in ratio 2:2:1:1, in correcting 
reproductive dysfunction in male diabetic rats. 
MTEC was reported to improve all testiculo-
somatic indices that were earlier deteriorated by 
STZ injection. Quercetin, which is a flavonoid 
that is also found abundantly in onions, prevented 
all histological abnormalities that are usually 
associated with DM in STZ treated Wistar rats 
(30). Additionally, Long et al (8) evaluated the 
effect of pharmaceutical product, scutellarin, an 
active component of Erigeron breviscapus 
(fleabane) in type 2 diabetes rat models. 
Scutellarin was found to significantly inhibit the 
formation of apoptotic cells and morphological 
damage in the testes caused by DM (8). 
Effects on spermatogenesis and sperm 
parameters: Amaranthus spinosus, Eugenia 
jambolana and MTEC increased sperm count 
significantly in diabetic rats (27, 28, 29). 
Quercetin reportedly restored epididymal sperm 
count, sperm motility and sperm viability in STZ-
induced diabetic rats (30). While both methanol 
and aqueous extracts of Zingiber officinale 
(Ginger) root were found to significantly enhance 
sperm parameters and sexual indices (31).
Effects on erectile function: Icariside II (ICA II), 
an active component of herba epimedii (horny 
goat weed) was investigated and found to 
improve erectile function in STZ-induced 
diabetic rats with ED. ICA II achieved this by 
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increasing the neuronal and endothelial Nitric 
Oxide Synthase (nNOS and eNOS) as well as the 
Vascular Endothelial Growth Factor (VEGF) in 
penile tissues. It also down-regulated the TGF-
â1/Smad2 pathway and decreased apoptotic 
index in the corpus cavernosum of diabetic rat 
after twelve weeks of oral treatment (32). S-Allyl 
Cysteine (SAC), a bioactive component of garlic 
significantly improved erectile function in 
diabetic rats after four weeks of treatment, owing 
to its ability to reduce formation of Reactive 
Oxygen Species (ROS) in penile tissue (33). 
Furthermore, caffeine had similar effect after 
eight weeks of treatment, acting via a different 
mechanism (34). Likewise, Cyanidin-3-O-â-D-
glucopyranoside (C3G); concentrated materials 
from mulberry fruit was reported to protect and 
improve erectile function in STZ-induced 
diabetic male Sprague-Dawley rats (35).
Hormonal effects: Both serum and testicular 
testosterone levels in diabetic rats were 
significantly increased after fifteen days of oral 
administration of Amaranthus spinosus stem and 
sixty days of oral treatment with ethyl acetate 
extract of Eugenia jambolana seed (27, 28). 
Cinnamomum zeylanicum (Cinnamon) and 
Zingiber officinale, when administered 
individually or combined increased serum 
testosterone, luteinizing hormone and follicle 
stimulating hormone, as well as enhanced 
spermatogenesis in STZ-induced diabetic rats 
(31, 36). The use of both plants appears to 
produce synergistic effect since these hormonal 
e ffec t s  were  grea te r  wi th  combined  
administration. MTEC and Quercetin are other 
substances reported to increase serum 
testosterone and enhance testicular antioxidative 
capacity in diabetic rats (29, 30). Curculigo 
orchioides (black musli) is one of the few 
medicinal plants whose Rhizome extract was 
specifically reported for their role in enhancing 
libido in experimental diabetic animals (37). The 
exact mechanism underlying this effect was not 
ascertained, however, modulation of the actions 
and blood levels of reproductive hormones may 
play a part.
Human studies
In contrast to the array of reports on 
scientific studies investigating the efficacy of 
numerous medicinal plants in the treatment of 
reproductive dysfunctions in experimentally 
induced DM in animals, only a very few human 
studies are available in this respect.
Many plants have been used empirically in the 
traditional settings to alleviate various 
reproductive dysfunctions especially poor libido, 
sexual asthenia and erectile dysfunction (26), but 
these have not been specifically investigated in 
diabetic patients. Curculigo orchioides is a herb 
known for its potent antioxidant and adaptogenic 
properties and used in ayurvedic medicine as a 
sexual tonic in diabetic men (37). This has been 
confirmed in diabetic animal models (37), but no 
report of any scientific study in diabetic humans 
is available.
A summary of some studies involving 
medicinal plants that have been reported for their 
efficacies in treating reproductive complications 
of DM is presented in table 1.
DISCUSSION
This review clearly re-emphasizes the 
possibility of occurrence of male infertility as a 
complication of DM especially when poorly 
managed. It may further justify the recent 
equitable distribution of the etiology of infertility 
between both sexes, rather than the usual 
stigmatization of the female partner alone (26), 
since DM is not gender biased. As mentioned 
earlier, the complications of DM cuts across most 
systems of the body, but the reproductive effects 
are topical owing to the sensitive nature and 
cultural implications of infertility in many 
societies (38).
From many of the studies reviewed, it is 
obvious that the increased generation of 
oxidative stress is central in the pathophysiology 
of most of the reproductive dysfunctions seen in 
DM (2, 3, 16, 19) (see Fig.1). Oxidative stress has 
been linked directly or indirectly to the sustained 
hyperglycaemia characteristic of the disease and 
therefore a large number of plants investigated 
for antidiabetic properties were so used because 
of their antioxidant or antihyperglycaemic 
potential (6-8, 28, 30).
It is noteworthy, that a very large number 
of medicinal plants have been reported to be 
useful in the treatment of male reproductive 
dysfunctions and infertility (26). However, only a 
few of these have been investigated for their 
efficacy in the treatment of male reproductive 
dysfunctions secondary to DM. Likewise, a large 
fraction of medicinal plants known for their 
antidiabetic potentials has not been specifically 
investigated for the correction of the reproductive 
complications of DM. These aspects of diabetic 
research cannot be discarded especially when 
some plants like Dracaena arborea were found to 
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improve sexual function in diabetic rats without 
any significant effect on blood glucose (7). This 
implies that the correction of diabetic 
complications is not always dependent on 
antihyperglyceamic effect of a substance. 
The present review also revealed a 
striking paucity of information with regards to the 
exact efficacy of medical plants in the treatment 
of DM–induced reproductive dysfunction in 
men, since there were no human studies 
published within the scope of our review. 
Virtually all investigations in this field during the 
time frame of this study were carried out on 
animal models while a large number of these 
medicinal plants continued to be used empirically 
in various traditional settings without proper 
therapeutic trial. The need to change this cannot 
be overemphasized.
Erectile dysfunction is one of the most 
common reproductive dysfunctions in male 
diabetics and yet poorly investigated. Report 
from one study indicated a difference in response 
to therapy when comparing patients of DM-
induced ED to other patients of ED in the general 
population, with the diabetic patients showing 
poorer response (39, 40). Despite these reports, 
there was no single human study published within 
the period captured under this review that 
considered the effectiveness of medicinal plants 
in the treatment of DM-induced ED. There is 
therefore the need to specifically investigate 
many more of these medicinal plants and carry 
out an in-depth analysis of their therapeutic 
efficacies in the management of specific 
reproductive dysfunctions caused by DM in both 
animal models and human diabetic subjects. This 
will go a long way in instituting standard 
alternative therapies and improving the living 
conditions of many diabetic patients.
CONCLUSION
The use of medicinal plants in the general 
management of DM has offered a renewed hope 
of better therapeutic outcome but this however 
has not yielded any noticeable reduction in the 
prevalence of systemic complications, including 
reproductive dysfunctions in diabetic patients. 
This study highlighted the paucity of information 
with regards to the potentials of medicinal plants 
in correcting male reproductive dysfunctions 
caused by DM. It was therefore concluded from 
the review that, the use of medicinal plants in the 
management of DM-induced male reproductive 
dysfunction in humans is still largely empirical. 
Further scientific studies, as well as clinical 
therapeutic trials in human subjects are required 
to completely evaluate the role of these natural 
substances.  
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Table 1: Medicinal Plants used in treatment of male reproductive complications due to diabetes mellitus                      
                                                                                                            
          
KEY:
 
eNOS = Endothelial nitric oxide synthase.                     
 
nNOS = Nuclear nitric oxide synthase.                           
 
ICP = Intracavernous pressure.                                         
 
VEGF = Vascular endothelial growth    factor.          
                          
MTEC = 
 




cGMP = Cyclic Guanosine-
    
Monophosphate                                                                              
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FIG. 1: The impact of diabetes mellitus on the male reproductive system
 
